Astonea Labs Acquires 25.74% Stake Damaira Pharma

Astonea Labs Limited acquired ~25.74% equity stake in Damaira Pharmaceuticals Private Limited for INR 6.25 crore cash consideration.
52 lakh equity shares acquired at INR 12.02/share, funded via variation in IPO proceeds approved by shareholders on March 27, 2026.
Damaira Pharmaceuticals reported FY2024-25 turnover of ~INR 82.48 crore, up sharply from INR 25.16 crore in FY2023-24.
Transaction is arm's length, not a related party transaction, and required no specific governmental or regulatory approvals.